Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer
Open Access
- 4 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 30 (11), 1857-1864
- https://doi.org/10.1093/carcin/bgp206
Abstract
The tyrosine kinase (TK) family is an important regulator of signaling pathways that control a variety of physiological and pathological conditions, and a substantial proportion of TK genes are genetically altered in cancer. To clarify the somatic mutation profile of TK genes and discover potential targets for gastric cancer (GC) therapy, we undertook a systematic screening of mutations in the kinase domains of all human TK genes (636 exons of 90 genes) in 17 GC cell lines and 52 microdissected primary GCs with poorly differentiated histology. We identified 26 non-synonymous alterations (22 genes in total) that included 11 sequence alterations in cell lines and 15 somatic mutations in primary tumors. Recurrent mutations were found in four genes including a known oncogene ( NTRK3 ), the Src kinase family ( LTK and CSK ) and a potential Wnt signal activator ( ROR2 ). In addition, we analyzed copy number alterations of all the TK gene loci in the same cohort samples by array-based comparative genomic hybridization analysis and identified 24 high-level amplifications and two homozygous deletions. Both sequence alteration and frequent copy number aberration were detected in two TK genes ( HCK and ERBB2 ), strongly suggesting that they encode potential oncogenes in GC. Our focused and integrated analyses of systemic resequencing and gene copy number have revealed the novel onco-kinome profile of GC and pave the way to a comprehensive understanding of the GC genome.Keywords
This publication has 54 references indexed in Scilit:
- GenBankNucleic Acids Research, 2009
- HER2 YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapyProceedings of the National Academy of Sciences of the United States of America, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- The Genome Sequencer FLX™ System—Longer reads, more applications, straight forward bioinformatics and more complete data setsJournal of Biotechnology, 2008
- Brk is coamplified with ErbB2 to promote proliferation in breast cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008
- GenBankNucleic Acids Research, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancerNature Genetics, 2005
- A census of human cancer genesNature Reviews Cancer, 2004